Karen Ross
About Karen Ross
Karen Ross is the Sales Learning Lead at Bristol-Myers Squibb in New Jersey, with over 30 years of experience in the pharmaceutical industry. She has held multiple leadership roles in hematology and cardiovascular product management and played a key role in the launch of Apixaban.
Company
Karen Ross currently works at Bristol-Myers Squibb, a leading biopharmaceutical company. She is based in New Jersey, United States, where she holds multiple key positions within the organization.
Title
Karen Ross holds the titles of Sales Learning Lead and Hematology Commercial Lead at Bristol-Myers Squibb. Her roles reflect her extensive background and leadership capabilities in these areas.
Professional Experience at Bristol-Myers Squibb
Karen Ross boasts over 30 years of experience in the pharmaceutical industry. At Bristol-Myers Squibb, she has advanced through various leadership roles. She initially worked as a Senior Market Research Analyst for 21 years. Subsequently, she served as Product Manager, Launch Lead for Apixaban, Senior Product Manager Eliquis, and Senior Product Manager Hematology. Her tenure at the company underscores her adaptability and expertise across different functions.
Educational Background
Karen Ross holds a Master of Business Administration with a focus on Marketing from Concordia University, obtained between 1986 and 1991. Additionally, she holds a degree from McGill University, where she studied from 1981 to 1984. Her academic achievements have equipped her with foundational and advanced knowledge pertinent to her career in the pharmaceutical industry.
Leadership in Hematology and Cardiovascular Product Management
Throughout her career, Karen Ross has held multiple leadership roles, particularly in the areas of hematology and cardiovascular product management. Notably, she played a key role in the launch of Apixaban, a significant product for Bristol-Myers Squibb. Her leadership in these critical therapeutic areas underscores her strategic vision and impact on the company's product portfolio.